Savara Inc Proceeds from Issuance or Sale of Equity
Savara Inc (SVRA) reported Proceeds from Issuance or Sale of Equity of $29.40 million for the 38-month period ending 2017-03-31, per its 10-Q filed 2017-05-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2017-05-09
- Savara Inc proceeds from issuance or sale of equity for the quarter ending 2016-03-31 was $17.50M.
- Savara Inc proceeds from issuance or sale of equity for the quarter ending 2013-09-30 was $0.00.
- Savara Inc proceeds from issuance or sale of equity for fiscal 2014 was $15.30M.
| Period end | Proceeds from Issuance or Sale of Equity 1 month | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 9 month | Proceeds from Issuance or Sale of Equity 12 month | Proceeds from Issuance or Sale of Equity 14 month | Proceeds from Issuance or Sale of Equity 17 month | Proceeds from Issuance or Sale of Equity 20 month | Proceeds from Issuance or Sale of Equity 23 month | Proceeds from Issuance or Sale of Equity 35 month | Proceeds from Issuance or Sale of Equity 38 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-03-31 | $29.40M 10-Q · filed 2017-05-09 | ||||||||||
| 2016-12-31 | $29.40M 10-K · filed 2017-03-06 | ||||||||||
| 2016-03-31 | $17.50M 10-Q · filed 2016-05-06 | ||||||||||
| 2016-02-29 | $8.00M 10-Q · filed 2017-05-09 | ||||||||||
| 2015-12-31 | $17.50M 10-K · filed 2016-03-14 | ||||||||||
| 2015-09-30 | $17.50M 10-Q · filed 2015-11-12 | ||||||||||
| 2015-06-30 | $17.50M 10-Q · filed 2015-08-12 | ||||||||||
| 2015-03-31 | $15.40M 10-Q · filed 2015-05-11 | ||||||||||
| 2014-12-31 | $15.30M 10-K · filed 2015-03-24 | ||||||||||
| 2014-11-30 | $21.00M 10-K · filed 2017-03-06 | ||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | $28.10M 10-Q · filed 2013-11-04 | |||||||||
| 2013-06-30 | $28.10M 10-K · filed 2015-03-24 | $28.10M 10-Q · filed 2013-08-05 | |||||||||
| 2011-11-30 | $17.00M 10-K · filed 2013-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |